FDA Approved: RELAFEN DS — Original Application (Carwin Pharmaceutical Associates, LLC)

View source ↗

Summary

FDA approval of RELAFEN DS (nabumetone) through an original generic application by Carwin Pharmaceutical Associates, expanding access to this NSAID for osteoart…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis
• Rheumatoid Arthritis

Drugs mentioned

• RELAFEN DS (nabumetone)

Snippet

ORIG AP for RELAFEN DS (NABUMETONE)